Global outcomes, surgical teams and COVID-19 pandemic: Will the same objectives of global surgery persist?

Pre-operative factors associated with short- and long-term outcomes in the patient with inguinal hernia: What does the current evidence say?

“…However, no recent study was found that aimed to evaluate the impact of different nutritional states and the evolution of overall outcomes of inguinal hernia repair. Similarly, in order to improve the quality of the evidence in surgery, more robust studies should be conducted in low- and middle-income countries, and to assess whether the behavior is similar or whether there are previously undescribed factors that may influence the quality of the evidence [ [49] , [50] , [51] ]. There is also a need for eco-epidemiological studies and genomic analyses [ 49 ], which will facilitate the understanding of the difference in risk between the different subgroups, and the recurrence or overall risk that certain individuals have, since they have higher rates of both intraoperative and post-operative complications.…”

Surgical research in Colombia part 1: Scientific and academic productivity of the Colombian research groups in surgery

“…Global surgery has become the undisputed starting point for addressing a myriad of problems in surgery today, from seeking access to specialized services for the care of surgical diseases that generate a high burden of disease, to improving the quality of surgical evidence, and to promoting surgical education and practice [ [1] , [2] , [3] , [4] , [5] , [6] ]. Despite the emphasis of the 2030 global surgery targets set by The Lancet commission for global surgery in 2015, barriers have persisted over the years with respect to scientific output and improvement in available evidence, mainly in middle- and low-income countries [ 3 , 6 ].…”

Acute coronary syndromes following COVID-19 vaccine application: Kounis syndrome or chance?

“…Actually, it cannot be determined with certainty that an acute coronary syndrome following the application of the COVID-19 vaccine corresponds to Kounis syndrome or if it is an incidental event due to subclinical coronary artery disease or decompensation of previous disease. New research on cardiac injury in COVID-19, both in the acute phase and during the post-COVID-19 syndrome, continues to emerge [ [9] , [10] , [11] , [12] ]. Further research is needed to investigate whether there is a possibility of silent myocardial injury [ 12 ], either by administration of vaccine doses or as a mechanism derived from SARS-Cov-2 infection.…”